GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Beneish M-Score

DaVita (DaVita) Beneish M-Score : -2.92 (As of Apr. 25, 2024)


View and export this data going back to 1995. Start your Free Trial

What is DaVita Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.92 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for DaVita's Beneish M-Score or its related term are showing as below:

DVA' s Beneish M-Score Range Over the Past 10 Years
Min: -2.92   Med: -2.75   Max: -2.56
Current: -2.92

During the past 13 years, the highest Beneish M-Score of DaVita was -2.56. The lowest was -2.92. And the median was -2.75.


DaVita Beneish M-Score Historical Data

The historical data trend for DaVita's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Beneish M-Score Chart

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.77 -2.76 -2.78 -2.69 -2.92

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.69 -2.86 -2.97 -2.88 -2.92

Competitive Comparison of DaVita's Beneish M-Score

For the Medical Care Facilities subindustry, DaVita's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where DaVita's Beneish M-Score falls into.



DaVita Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of DaVita for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9058+0.528 * 0.9307+0.404 * 1.0442+0.892 * 1.0457+0.115 * 0.9333
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0401+4.679 * -0.079447-0.327 * 0.9604
=-2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $2,416 Mil.
Revenue was 3145.747 + 3121.332 + 3000.369 + 2872.699 = $12,140 Mil.
Gross Profit was 1007.378 + 1054.017 + 944.525 + 814.51 = $3,820 Mil.
Total Current Assets was $3,138 Mil.
Total Assets was $16,894 Mil.
Property, Plant and Equipment(Net PPE) was $5,575 Mil.
Depreciation, Depletion and Amortization(DDA) was $745 Mil.
Selling, General, & Admin. Expense(SGA) was $1,474 Mil.
Total Current Liabilities was $2,642 Mil.
Long-Term Debt & Capital Lease Obligation was $10,599 Mil.
Net Income was 150.665 + 246.632 + 178.691 + 115.547 = $692 Mil.
Non Operating Income was -25.373 + -12.422 + 1.865 + 10.572 = $-25 Mil.
Cash Flow from Operations was 485.205 + 661.162 + 450.107 + 462.557 = $2,059 Mil.
Total Receivables was $2,551 Mil.
Revenue was 2916.888 + 2948.694 + 2926.757 + 2817.555 = $11,610 Mil.
Gross Profit was 828.207 + 863.139 + 909.969 + 799.026 = $3,400 Mil.
Total Current Assets was $3,155 Mil.
Total Assets was $16,928 Mil.
Property, Plant and Equipment(Net PPE) was $5,923 Mil.
Depreciation, Depletion and Amortization(DDA) was $733 Mil.
Selling, General, & Admin. Expense(SGA) was $1,355 Mil.
Total Current Liabilities was $2,620 Mil.
Long-Term Debt & Capital Lease Obligation was $11,196 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(2415.912 / 12140.147) / (2550.649 / 11609.894)
=0.199002 / 0.219696
=0.9058

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3400.341 / 11609.894) / (3820.43 / 12140.147)
=0.292883 / 0.314694
=0.9307

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3137.906 + 5574.897) / 16893.578) / (1 - (3155.292 + 5922.639) / 16928.252)
=0.484254 / 0.463741
=1.0442

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=12140.147 / 11609.894
=1.0457

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(732.602 / (732.602 + 5922.639)) / (745.443 / (745.443 + 5574.897))
=0.110079 / 0.117943
=0.9333

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1473.984 / 12140.147) / (1355.197 / 11609.894)
=0.121414 / 0.116728
=1.0401

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10598.723 + 2642.214) / 16893.578) / ((11195.685 + 2619.747) / 16928.252)
=0.783785 / 0.816117
=0.9604

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(691.535 - -25.358 - 2059.031) / 16893.578
=-0.079447

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

DaVita has a M-score of -2.92 suggests that the company is unlikely to be a manipulator.


DaVita (DaVita) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines

From GuruFocus

Q2 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024